phenobarbital has been researched along with Alagille Syndrome 1 in 1 studies
Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "It has been stated that arteriohepatic dysplasia is a form of biliary paucity with a good prognosis." | 1.28 | Long-term complications of arteriohepatic dysplasia. ( Freese, D; Grothe, RM; Schwarzenberg, SJ; Sharp, HL; Snover, DC, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schwarzenberg, SJ | 1 |
| Grothe, RM | 1 |
| Sharp, HL | 1 |
| Snover, DC | 1 |
| Freese, D | 1 |
1 other study available for phenobarbital and Alagille Syndrome 1
| Article | Year |
|---|---|
Long-term complications of arteriohepatic dysplasia.
Topics: Adolescent; Adult; Alagille Syndrome; Child; Child, Preschool; Cholestyramine Resin; Drug Therapy, C | 1992 |